データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 A.m. ET
ANI Pharmaceuticals Launches Estradiol Gel After Final FDA Approval
ANI Pharmaceuticals ANIP FDA Approval; IDEAYA IDYA Phase 1 Data
ANI Pharmaceuticals Price Target Raised to $62 From $60 at Truist
ANI Pharmaceuticals Is Maintained at Hold by Truist Securities